Business Context and Reporting Period
Cytosorbents Corp filed a Form 8-K Current Report on March 10, 2016. The filing addresses corporate governance matters, specifically amendments to the Company's Code of Business Conduct and Ethics.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is non-financial in nature.
Material Changes
On March 10, 2016, the Audit Committee and the Nominating and Corporate Governance Committee amended and restated the Company's Code of Business Conduct and Ethics. The primary change involves providing information regarding the Company's new Fraud and Ethics reporting hotline.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, management commentary on operations, or discussion of risks and contingencies. The full text of the amended Code is available on the Company's website under "Investor Relations-Governance Documents."
Investor Verification Checklist
- Verify the implementation details of the new Fraud and Ethics reporting hotline.
- Review the full text of the amended Code of Business Conduct and Ethics on the Company's website.
- Confirm that no other material events occurred on the reporting date not disclosed in this specific 8-K item.